发明名称 PHARMACEUTICAL COMPOSITIONS COMPRISING PLANT EXTRACTS AND METHODS FOR REDUCING DURATION OF A COMMON COLD USING SAME
摘要 The present disclosure describes pharmaceutical compositions and methods for reducing duration, intensity, and/or bothersomeness of common colds in humans and for reducing severity or duration of common cold symptoms such as nasal congestion, runny nose, watery eyes, dry/scratchy throat and sneezing in humans exhibiting such symptoms. The compositions herein comprise extracts of at least one of Luffa Operculata (L. operculata), S. officinale (V. sabadilla), and Galphimia Glauca (G. glauca) in a pharmaceutically acceptable carrier, and in various embodiments, comprise a mixture of all three Luffa Operculata (L. operculata) 10% extract MT, S. officinale (V. sabadilla) 3× extract, and Galphimia Glauca (G. glauca) 10% extract MT in a pharmaceutically acceptable carrier.
申请公布号 US2017100446(A1) 申请公布日期 2017.04.13
申请号 US201615386318 申请日期 2016.12.21
申请人 Matrixx Initiatives, Inc. 发明人 Clarot Timothy L.;Ascarate Arlene M.
分类号 A61K36/88;A61K36/42;A61K36/185;A61K47/18;A61K47/38;A61K47/26;A61K47/12;A61K47/02;A61K9/00;A61K47/10 主分类号 A61K36/88
代理机构 代理人
主权项 1. A method for reducing duration of common cold symptoms, said method comprising: nasally administering to a human exhibiting common cold symptoms a therapeutically effective amount of a composition comprising: (a) from about 0.001 wt. % to about 0.5 wt. % of a mixture of L. operculata 10 wt. % extract (MT), S. officinale 3× extract, and G. glauca 10 wt. % extract (MT); (b) a thickener at from about 0.001 wt. % to about 10 wt. %; and (c) a pharmaceutically acceptable carrier comprising at least about 90 wt. % water, wherein each wt. % is based on the total weight of the composition, wherein the common cold symptoms are selected from the group consisting of: nasal congestion, runny nose, watery eyes, dry/scratchy throat and/or sneezing.
地址 Scottsdale AZ US